S
Strand Therapeutics
Biotechnology platform intended to create gene therapies powered by synthetic biology
About Strand Therapeutics
Strand Therapeutics is a pioneering biotech startup that is developing a unique platform for creating programmable, long-acting mRNA therapeutics. These therapeutics are designed to deliver precise, multi-functional treatments that could potentially cure various diseases. The company's groundbreaking technology allows mRNA to target only diseased cells, thereby increasing the therapeutic window and reducing potential harm to healthy cells. This is achieved by programming logic-based circuits into the mRNA, enabling it to sense different cell types and activate only in the presence of disease.
Read full description
Strand Therapeutics operates in the biotech market, serving clients in the medical and healthcare sectors. Its primary focus is on developing improved treatment options for cancer and other life-threatening diseases. The company's business model revolves around the development and commercialization of its proprietary mRNA therapeutics. Revenue is generated through the sale of these therapeutics to healthcare providers and institutions.
The company is also open to collaborations and partnerships to expand its programs. As an emerging biotech company, Strand Therapeutics offers vast learning and growth opportunities, including exposure to all aspects of building a company.
At a glance
- Founded
- 2017
- Headquarters
- Cambridge, United States
- Sector
- Biotech & Life Sciences
- Power Law
- Colt$25–100M revenue
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Playground Global
ANRI
Series A14 investors entered at this stage
Camford Capital
Redmile Group
BeOne Medicines
FPV Ventures- PPPotentum Partners
Eli Lilly
Kinnevik
Amgen Ventures
Alderline Group
ICONIQ Capital
LG Technology Ventures
Gradiant
JIC Venture Growth Investments
Regeneron Ventures
Series B and later9 investors entered at this stage
- LVLG Technology Ventures
- MTMassachusetts Institute of Technology
- RVRegeneron Ventures
- ICONIQ Capital
- JIJIC Venture Growth Investments
- Gradiant
- AGAlderline Group
- Kinnevik
- AVAmgen Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Market sentiment
An AI-synthesised read of the highest-engagement posts about Strand Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Strand Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.